Attached files

file filename
10-K - 10-K - HUMAN GENOME SCIENCES INCw81670e10vk.htm
EX-10.2 - EX-10.2 - HUMAN GENOME SCIENCES INCw81670exv10w2.htm
EX-23.1 - EX-23.1 - HUMAN GENOME SCIENCES INCw81670exv23w1.htm
EX-31.1 - EX-31.1 - HUMAN GENOME SCIENCES INCw81670exv31w1.htm
EX-12.1 - EX-12.1 - HUMAN GENOME SCIENCES INCw81670exv12w1.htm
EX-32.1 - EX-32.1 - HUMAN GENOME SCIENCES INCw81670exv32w1.htm
EX-10.3 - EX-10.3 - HUMAN GENOME SCIENCES INCw81670exv10w3.htm
EX-31.2 - EX-31.2 - HUMAN GENOME SCIENCES INCw81670exv31w2.htm
EX-21.1 - EX-21.1 - HUMAN GENOME SCIENCES INCw81670exv21w1.htm
EXHIBIT 32.2
Certification of Principal Financial Officer
Pursuant to 18 U.S.C. 1350
(Section 906 of the Sarbanes-Oxley Act of 2002)
I, David P. Southwell, Executive Vice President and Chief Financial Officer (principal financial officer) of Human Genome Sciences, Inc. (the “Registrant”), certify, to the best of my knowledge, based upon a review of the Annual Report on Form 10-K for the period ended December 31, 2010 of the Registrant (the “Report”), that:
(1)   The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and
 
(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
         
     
  /s/ David P.Southwell    
  Name:   David P. Southwell   
  Date: February 24, 2011